Trademark: 87668730
Word
VIDENS LIFE SCIENCES
Status Date
Tuesday, December 27, 2022
Registration Number
6932878
Registration Date
Tuesday, December 27, 2022
Filing Date
Wednesday, November 1, 2017
Published for Opposition
Tuesday, October 11, 2022
44 Consulting for medical toxicology in the field of neurodegenerative diseases and disorders; providing targeted, individualized treatment regimens, therapies or combination therapy for patients suffering from neurodegenerative diseases and disorders; medical testing for diagnostic or treatment purposes in the field of neurodegenerative diseases and disorders
10 Medical apparatus for the treatment of neurodegenerative diseases; medical instruments and articles, namely, medical laboratory apparatus for diagnosis and analysis of neurodegenerative diseases; analysis apparatus for medical purposes, namely, apparatus for blood test for use in the fields of neurology and neurobiology; diagnostic apparatus for medical purposes, for diagnosing Alzheimer's disease and other dementias, Parkinson's disease and PD-related disorders, Prion disease, Motor neurone diseases, Huntington's disease, Spinocerebellar ataxia, Spinal muscular atrophy for use in the fields of neurology and neurobiology; medical diagnostic apparatus for the detection of neurodegenerative diseases and conditions; surgical, medical apparatus and instruments for the prevention, treatment and repair of neurodegenerative diseases and disorders; medical testing apparatus used for the treatment of cognitive deficiencies, neurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities
42 Pre-clinical and clinical services for formulation research, namely, conducting clinical trials for others, clinical research, medical research in the field of neurodegenerative diseases; conducting clinical trials for others for diagnostic tests and for pharmaceutical preparations in the field of neurodegenerative diseases; scientific and toxicology research services in the field of neuroscience and neurodegenerative diseases; biopharmaceutical research for development of targeted therapies for use in the treatment of neurodegenerative diseases and disorders; providing medical testing services for research purposes and medical and scientific research information in the fields of degenerative and neurodegenerative diseases; Consulting for pharmacology in the field of neurodegenerative diseases and disorders
The English translation of the word "VIDENS" in the mark is "knowledge".
"LIFE SCIENCES"
Dec 27, 2022
Notice Of Registration Confirmation Emailed
Dec 27, 2022
Registered-Principal Register
Oct 11, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 11, 2022
Published For Opposition
Sep 21, 2022
Notification Of Notice Of Publication E-Mailed
Sep 6, 2022
Examiners Amendment Mailed
Sep 6, 2022
1(B) Basis Deleted; New Basis Requested
Jul 6, 2022
Notice Of Allowance Cancelled
Aug 10, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 8, 2022
Sou Extension 1 Granted
Aug 8, 2022
Sou Extension 1 Filed
Aug 8, 2022
Teas Extension Received
Aug 3, 2022
Attorney Review/Decision On Amendment Required
Aug 3, 2022
Petition To Director - Change Basis - Granted
Aug 1, 2022
Assigned To Petition Staff
Jul 6, 2022
Teas Petition To Amend Basis Received
Feb 8, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 30, 2021
Teas Change Of Correspondence Received
Dec 30, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 30, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 14, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 14, 2021
Published For Opposition
Nov 24, 2021
Notification Of Notice Of Publication E-Mailed
Nov 5, 2021
Approved For Pub - Principal Register
Nov 5, 2021
Examiner's Amendment Entered
Nov 5, 2021
Notification Of Examiners Amendment E-Mailed
Nov 5, 2021
Examiners Amendment E-Mailed
Nov 5, 2021
Examiners Amendment -Written
Oct 27, 2021
Teas/Email Correspondence Entered
Oct 27, 2021
Correspondence Received In Law Office
Oct 27, 2021
Teas Response To Office Action Received
Sep 7, 2021
Notification Of Non-Final Action E-Mailed
Sep 7, 2021
Non-Final Action E-Mailed
Sep 7, 2021
Non-Final Action Written
Jul 30, 2021
Suspension Checked ¿ To Attorney For Action
Jul 14, 2021
Assigned To Examiner
Apr 15, 2021
Suspension Checked ¿ To Attorney For Action
Oct 14, 2020
Report Completed Suspension Check Case Still Suspended
Oct 6, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 6, 2020
Teas Change Of Correspondence Received
Oct 6, 2020
Teas Withdrawal As Domestic Representative Received
Oct 6, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 6, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 6, 2020
Teas Change Of Owner Address Received
Mar 23, 2020
Report Completed Suspension Check Case Still Suspended
Sep 16, 2019
Report Completed Suspension Check Case Still Suspended
Mar 13, 2019
Report Completed Suspension Check Case Still Suspended
Mar 13, 2019
Assigned To Lie
Sep 5, 2018
Notification Of Letter Of Suspension E-Mailed
Sep 5, 2018
Letter Of Suspension E-Mailed
Sep 5, 2018
Suspension Letter Written
Aug 15, 2018
Teas/Email Correspondence Entered
Aug 14, 2018
Correspondence Received In Law Office
Aug 14, 2018
Teas Response To Office Action Received
Feb 14, 2018
Notification Of Non-Final Action E-Mailed
Feb 14, 2018
Non-Final Action E-Mailed
Feb 14, 2018
Non-Final Action Written
Feb 12, 2018
Assigned To Examiner
Nov 11, 2017
New Application Office Supplied Data Entered In Tram
Nov 4, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
